Zvast Biotechnology
Facilities
Zvast Biotechnology pharmacology platform and team possess extensive professional expertise and experience. After years of accumulated experience, they have supported dozens of client pharmacology and efficacy project submissions. The team has progressively built and refined a library of tumor and non-tumor cell and animal models, providing various effective efficacy models according to client needs to deliver pharmacology and efficacy services. The platform has established a rich collection of CDX models, as well as various non-tumor disease animal models. It can support a wide range of drug types, including small molecule compounds, peptides, antibody drugs (monoclonal antibodies, bispecific/multispecific antibodies, nanobodies, etc.), CGT products (immune cell therapy products, stem cell therapy products, etc.), and nucleic acid drugs. The constructed animal species include non-human primates, mice and rats of various sizes, rabbits, guinea pigs, pigs, dogs, and sheep.
Zvast Biotechnology adheres to global standards in quality management systems and has obtained AAALAC and ISO certifications, possessing international service capabilities. It provides pharmaceutical companies and research institutions worldwide with precise pharmacological services that comply with both domestic and international regulatory standards.
